Free Trial

Cue Biopharma (CUE) SEC Filings & 10K Form

Cue Biopharma logo
$0.71 +0.11 (+17.61%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$0.73 +0.02 (+2.67%)
As of 05/22/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cue Biopharma SEC Filings

DateFilerForm TypeView
04/25/2025
3:00 PM
Cue Biopharma (Filer)
Form DEFA14A
04/15/2025
3:44 PM
Cue Biopharma (Filer)
Form 424B5
04/14/2025
4:17 PM
Cue Biopharma (Filer)
Form 424B5
04/14/2025
3:00 PM
Cue Biopharma (Filer)
Form PRE 14A
03/31/2025
3:00 PM
Cue Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:14 PM
Bleichroeder LP (Filed by)
Cue Biopharma (Subject)
Form SCHEDULE 13G/A
12/18/2024
3:00 PM
Cue Biopharma (Issuer)
PASSERI DANIEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
3:00 PM
Baker Daniel G. (Reporting)
Cue Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2024
3:00 PM
Baker Daniel G. (Reporting)
Cue Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2024
4:07 PM
Bleichroeder LP (Filed by)
Cue Biopharma (Subject)
Form SCHEDULE 13G/A
10/04/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:17 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:05 PM
Cue Biopharma (Filer)
Form 424B5
09/26/2024
3:32 PM
Cue Biopharma (Filer)
Form 424B5
09/10/2024
3:00 PM
Cue Biopharma (Filer)
Form DEF 14A
09/03/2024
3:30 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
3:00 PM
Cue Biopharma (Filer)
Form PRE 14A
08/16/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2024
3:00 PM
Cue Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CUE) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners